1
|
Caruntu C, Boda D, Dumitrascu G,
Constantin C and Neagu M: Proteomics focusing on immune markers in
psoriatic arthritis. Biomarkers Med. 9:513–528. 2015. View Article : Google Scholar
|
2
|
Krueger JG and Bowcock A: Psoriasis
pathophysiology: Current concepts of pathogenesis. Ann Rheum Dis.
64:30–36. 2005. View Article : Google Scholar
|
3
|
Kasper D, Fauci AS, Hausner AS, Longo D,
Jameson J and Loscalzo J: Eczema, psoriasis, cutaneous infections,
acne, and other common skin disorders. Harrison's Principles of
Internal Medicine. 1. 19th. McGraw Hill; New York: pp. 347–348.
2012
|
4
|
Di Nuzzo S, Feliciani C, Cortelazzi C,
Fabrizi G and Pagliarello C: Immunopathogenesis of psoriasis:
Emphasis on the role of Th17 cells. Int Trends Immun. 2:3121–2326.
2014.
|
5
|
Boca AN, Tataru A, Buzoianu AD, Pincelli C
and Socaciu C: Pharmacological benefits of herbal formulations in
the management of psoriasis vulgaris. Not Bot Horti Agrobot.
42:1–8. 2014.
|
6
|
Bowcock AM and Cookson WO: The genetics of
psoriasis, psoriatic arthritis and atopic dermatitis. Hum Mol
Genet. 13:R43–R55. 2004. View Article : Google Scholar : PubMed/NCBI
|
7
|
Traub M and Marshall K:
Psoriasis-pathophysiology, conventional, and alternative approaches
to treatment. Altern Med Rev. 12:319–330. 2007.PubMed/NCBI
|
8
|
Kivelevitch DN, Tahhan PV, Bourren P,
Kogan NN, Gusis SE and Rodríguez EA: Self-medication and adherence
to treatment in psoriasis. Int J Dermatol. 51:416–419. 2012.
View Article : Google Scholar : PubMed/NCBI
|
9
|
Jensen P: Use of alternative medicine by
patients with atopic dermatitis and psoriasis. Acta Derm Venereol.
70:421–424. 1990.PubMed/NCBI
|
10
|
Bal LM, Meda V, Naik SN and Satya S: Sea
buckthorn berries: A potential source of valuable nutrients for
nutraceuticals and cosmoceuticals. Food Res Int. 44:1718–1727.
2011. View Article : Google Scholar
|
11
|
Suryakumar G and Gupta A: Medicinal and
therapeutic potential of Sea buckthorn (Hippophae rhamnoides
L.). J Ethnopharmacol. 138:268–278. 2011. View Article : Google Scholar : PubMed/NCBI
|
12
|
Boca A, Ilies R, Nielsen L, Pop R, Vesa S,
Buzoianu A and Tataru A: The effects of sea buckthorn and tomatinee
extracts on skin lesions. Rev SRD. 61:89–96. 2016.
|
13
|
Deng S, May BH, Zhang AL, Lu C and Xue
CCL: Topical herbal medicine combined with pharmacotherapy for
psoriasis: A systematic review and meta-analysis. Arch Dermatol
Res. 305:179–189. 2013. View Article : Google Scholar : PubMed/NCBI
|
14
|
Boda D, Negrei C, Nicolescu F and Bǎlǎlǎu
C: Assessment of some oxidative stress parameters in methotrexate
treated psoriasis patients. Farmacia. 62:704–710. 2014.
|
15
|
Negrei C, Arsene AL, Toderescu CD, Boda D
and Ilie M: Acitretin treatment in psoriazis may influence the cell
membrane fluidity. Farmacia. 60:767–772. 2012.
|
16
|
Olteanu R, Constantin MM, Zota A,
Dorobanțu DM, Constantin T, Șerban ED, Bălănescu P, Mihele D and
Gheucă Solovăstru L: original clinical experience and approach to
treatment study with interleukine 12/23 inhibitor in
moderate-to-severe psoriasis patients. Farmacia. 64:2–5. 2016.
|
17
|
Batani A, Brănișteanu DE, Ilie MA, Boda D,
Ianosi S, Ianosi G and Caruntu C: Assessment of dermal papillary
and microvascular parameters in psoriasis vulgaris using in
vivo reflectance confocal microscopy. Exp Ther Med.
15:1241–1246. 2018.PubMed/NCBI
|
18
|
Căruntu C, Boda D, Căruntu A, Rotaru M,
Baderca F and Zurac S: In vivo imaging techniques for
psoriatic lesions. Rom J Morphol Embryol. 55:1191–1196.
2014.PubMed/NCBI
|